Clarivate Plc acquired Bioinfogate, a transaction announced in August 2021.
Acquired Bioinfogate (OFF-X translational drug-safety intelligence) to strengthen the life-sciences data and analytics offering; consideration not disclosed.
Acquired Bioinfogate (OFF-X translational drug-safety intelligence) to strengthen the life-sciences data and analytics offering; consideration not disclosed.
... Bioinfogate, which was completed in August 2021 ... the respective acquisition date of August 3, 2021 for Bioinfogate.
Advisory firms were not disclosed for this transaction.